ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 89 filers reported holding ALLOVIR INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,022 | -36.8% | 82,336 | 0.0% | 0.05% | +10.2% |
| Q2 2023 | $279,942 | -13.7% | 82,336 | 0.0% | 0.05% | -26.9% |
| Q1 2023 | $324,404 | -23.2% | 82,336 | 0.0% | 0.07% | -26.4% |
| Q4 2022 | $422,384 | -35.0% | 82,336 | 0.0% | 0.09% | -40.1% |
| Q3 2022 | $650,000 | +102.5% | 82,336 | 0.0% | 0.15% | +76.7% |
| Q2 2022 | $321,000 | -42.3% | 82,336 | 0.0% | 0.09% | -38.6% |
| Q1 2022 | $556,000 | -47.8% | 82,336 | 0.0% | 0.14% | -32.4% |
| Q4 2021 | $1,065,000 | -48.4% | 82,336 | 0.0% | 0.21% | -36.1% |
| Q3 2021 | $2,063,000 | +27.0% | 82,336 | 0.0% | 0.32% | +61.2% |
| Q2 2021 | $1,625,000 | -15.7% | 82,336 | 0.0% | 0.20% | -43.4% |
| Q1 2021 | $1,927,000 | -39.1% | 82,336 | 0.0% | 0.36% | +11.6% |
| Q4 2020 | $3,165,000 | +26.4% | 82,336 | -9.6% | 0.32% | -54.4% |
| Q3 2020 | $2,504,000 | – | 91,057 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |